$0.3410
-0.019-5.28%
At close: Aug 14, 5:00 PM EST
$0.3446
0.003611.06%
After Hours: Aug 14, 7:04 PM EST
Kairos Pharma (KAPA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.03 | $-0.09 | $-0.05 |
| Actual | $-0.08 | $-0.07 | $-0.07 | $-0.08 |
| Surprise | -14.3% | -133.3% | +22.2% | -60.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q2 '26E | Q3 '26E | Q4 '26E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.09 | $-0.09 | $-0.11 |
| Revenue | |||
| Consensus | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 13, 2026 | $-0.08 | $-0.07 | -14.3 % |
| Q4 | Mar 31, 2026 | $-0.07 | $-0.03 | -133.3 % |
| Q3 | Nov 14, 2025 | $-0.07 | $-0.09 | 22.2 % |
| Q2 | Aug 12, 2025 | $-0.08 | $-0.05 | -60.0 % |